Cargando…
Anticoagulant and Antiplatelet Use Among Hemodialysis Patients in the United States Without Medicare
Autores principales: | Boggs, Robert, Yang, Lingfeng, Lautsch, Dominik, Ramey, Dena Rosen, Liu, Sarah, Atkins, G. Brandon, McMullan, Ciaran Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969163/ https://www.ncbi.nlm.nih.gov/pubmed/36860290 http://dx.doi.org/10.1016/j.xkme.2022.100579 |
Ejemplares similares
-
Hemodialysis Access Type and Access Patency Loss: An Observational Cohort Study
por: Roetker, Nicholas S., et al.
Publicado: (2022) -
Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study
por: Roetker, Nicholas S., et al.
Publicado: (2022) -
Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data
por: Weiss, Tracey J., et al.
Publicado: (2022) -
Outpatient cervical brachytherapy in the setting of ongoing antiplatelet therapy or oral anticoagulation
por: Valakh, Vladimir, et al.
Publicado: (2018) -
Prostate biopsy and fiducial placement in the same sitting- a good option during COVID pandemic as well as in patients on anticoagulants/antiplatelets
por: Sen, Anitha, et al.
Publicado: (2021)